Login / Signup

Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review.

Jung Yin TsangMatthew SperrinThomas BlakemanRupert A PayneDarren Ashcroft
Published in: BMJ open (2024)
Improved strategies are needed to target patients with polypharmacy, which should consider patient perspectives, individual factors and clinical appropriateness. The development of a cross-cutting measure of problematic polypharmacy that consistently incorporates adjustment for multimorbidity may be a valuable next step to address frequent confounding.
Keyphrases
  • primary care
  • adverse drug
  • case report
  • emergency department